Aplab confirms full utilization of ₹6.29 crore rights issue proceeds
Aplab Limited has fully utilized the ₹6.29 crore received from its partial rights issue call in Q2FY26. Funds were allocated to repay a ₹2.75 crore loan and support working capital needs, with the remaining ₹17.59 crore of the issue yet to be called. Monitoring agency Infometrics confirmed compliance with SEBI regulations.

*this image is generated using AI for illustrative purposes only.
Aplab Limited confirmed the complete utilization of proceeds from its rights issue for the quarter ended June 30, 2026. The company utilized the entire ₹6.29 crore received during Q2FY26 towards its stated objectives, including working capital funding and loan repayment, with no balance remaining as of the quarter-end.
The rights issue, which closed on July 3, 2025, involved the issuance of 1,25,70,000 equity shares at a price of ₹5 per share (including a premium of ₹2.50). Although the total proposed issue size was ₹23.88 crore, the company called only ₹5 per share in Q2FY26, resulting in the receipt of ₹6.29 crore. The remaining portion of ₹14 per share (aggregating to ₹17.59 crore) remains uncalled and is yet to be invoked.
Utilization Breakdown
Infometrics Valuation and Rating Limited, acting as the monitoring agency, verified that the funds were deployed strictly in accordance with the Letter of Offer dated May 27, 2025. The statutory auditors, M/s. R. Bhargava & Associates, issued a certificate dated August 5, 2026, confirming no deviations from the expenditure plan.
| Object Head | Proposed Amount (₹ crore) | Amount Utilized (₹ crore) | Status |
|---|---|---|---|
| Working Capital Requirements | 15.00 | 3.03 | Ongoing |
| Repayment of Loan | 2.75 | 2.75 | Completed |
| General Corporate Purpose | 5.63 | 0.26 | Ongoing |
| Total | 23.38 | 6.04 | Fully Utilized |
Note: The total utilized amount of ₹6.04 crore aligns with the net proceeds after estimated issue-related expenses of ₹0.50 crore from the gross receipt of ₹6.29 crore.
What the Numbers Show
The deployment pattern reveals a strategic focus on debt reduction and immediate liquidity needs. The company fully repaid a ₹2.75 crore loan from M/s Laxmimanak Finance Pvt. Ltd., eliminating this specific liability. Concurrently, ₹3.03 crore was directed towards working capital, supporting the company’s objective to reduce trade payable days from 101 (as of December 31, 2024) to 76 in FY26, and trade receivable days from 142 to 95. This allocation suggests an intent to optimize the cash conversion cycle through improved supplier terms and stricter credit controls.
Regulatory Compliance
The company reported no material deviations from the objects of the issue. As per SEBI ICDR Regulations, 2018, unutilized proceeds may be carried forward to subsequent fiscals if not deployed within the proposed timeline due to factors beyond control. Since only a portion of the issue price was called, the non-utilization of the entire proposed ₹23.38 crore net proceeds by FY26 is not considered a deviation. The company plans to utilize the balance proceeds in subsequent periods upon making further calls, subject to regulatory approvals.
Historical Stock Returns for Aplab
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.09% | -0.37% | -28.56% | -18.96% | +51.13% | +345.93% |
When does Aplab Limited plan to invoke the remaining uncalled capital of ₹14 per share, and what specific operational milestones will trigger this call?
How will the reduction of trade payable days from 101 to 76 impact supplier relationships and potential credit terms in the near term?
Given the partial utilization of proceeds, are there any anticipated regulatory hurdles or additional SEBI approvals required for deploying the remaining ₹17.59 crore?


































